Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease

Experimental and Therapeutic Medicine

Volumn 7, Issue 2, 2014, Pages 365-370

  Lin, Zhihui ^a   Cai, Fangfang ^a   Lin, Ning ^a   Ye, Jinli ^a   Zheng, Qiqi ^a   Ding, Guisheng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Glutamine; Nonalcoholic fatty liver disease; Nuclear factor B; Oxidative stress

Indexed keywords

GLUTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

EID: 84890520740     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1434     Document Type: Article

References (31)

1. Day CP: Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med 6: 19-25, 2006.
2. Yang S, Zhu H, Li Y, et al: Mitochondrial adaptations to obesity related oxidant stress. Arch Biochem Biophys 378: 259-268, 2000.
3. Madan K, Bhardwaj P, Thareja S, Gupta SD and Saraya A: Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 40: 930-935, 2006.
4. Browning JD and Horton JD: Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152, 2004.
5. Narasimhan S, Gokulakrishnan K, Sampathkumar R, et al: Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem 43: 815-821, 2010.
6. Stangl R, Szijártó A, Ónody P, et al: Reduction of liver ischemia-reperfusion injury via glutamine pretreatment. J Surg Res 166: 95-103, 2011.
7. Zhang WX, Zhou LF, Zhang L, et al: Protective effects of glutamine preconditioning on ischemia-reperfusion injury in rats. Hepatobiliary Pancreat Dis Int 10: 78-82, 2011.
8. Peng HC, Chen YL, Chen JR, et al: Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats. J Nutr Biochem 22: 282-288, 2011.
9. Kessel A, Toubi E, Pavlotzky E, et al: Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat. Clin Exp Immunol 151: 341-347, 2008.
10. Kul M, Vurucu S, Demirkaya E, et al: Enteral glutamine and/or arginine supplementation have favorable effects on oxidative stress parameters in neonatal rat intestine. J Pediatr Gastroenterol Nutr 49: 85-89, 2009.
11. Tsai PH, Liu JJ, Chiu WC, Pai MH and Yeh SL: Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes. Clin Nutr 30: 124-129, 2011.
12. El-Sheikh NM and Khalil FA: L-arginine and L-glutamine as immunonutrients and modulating agents for oxidative stress and toxicity induced by sodium nitrite in rats. Food Chem Toxicol 49: 758-762, 2011.
13. Kim H: Glutamine as an immunonutrient. Yonsei Med J 52: 892-897, 2011.
14. Adams LA and Angulo P: Treatment of non-alcoholic fatty liver disease. Postgrad Med J 82: 315-322, 2006.
15. Yu JC, Jiang ZM and Li DM: Glutamine: a precursor of glutathione and its effect on liver. World J Gastroenterol 5: 143-146, 1999.
16. Tihan DN, Erbil Y, Seven R, et al: The effect of glutamine on oxidative damage in an experimental abdominal compartment syndrome model in rats. Ulus Trauma Acil Cerrahi Derg 17: 1-8, 2011.
17. Park HJ, DiNatale DA, Chung MY, et al: Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. J Nutr Biochem 22: 393-400, 2011.
18. Hardwick RN, Fisher CD, Canet MJ, Lake AD and Cherrington NJ: Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 38: 2293-2301, 2010.
19. Lee YM, Sutedja DS, Wai CT, et al: A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH). Hepatol Int 2: 196-201, 2008.
20. Tilg H: The role of cytokines in non-alcoholic fatty liver disease. Dig Dis 28: 179-185, 2010.
21. Tsai PH, Yeh CL, Liu JJ, Chiu WC and Yeh SL: Effects of dietary glutamine on inflammatory mediator gene expressions in rats with streptozotocin-induced diabetes. Nutrition 28: 288-293, 2012.
22. Jang HJ, Kwak JH, Cho EY, et al: Glutamine induces heat-shock protein-70 and glutathione expression and attenuates ischemic damage in rat islets. Transplant Proc 40: 2581-2584, 2008.
23. Pai MH, Chien YW, Tsai YH, Hu YM and Yeh SL: Glutamine reduces the expression of leukocyte integrins leukocyte function-associated antigen-1 and macrophage antigen-1 in mice exposed to arsenic. Nutr Res 28: 544-549, 2008.
24. Kaplowitz N and Tsukamoto H: Oxidative stress and liver disease. Prog Liver Dis 14: 131-159, 1996.
25. Videla LA, Tapia G, Rodrigo R, et al: Liver NF-kappa B and AP-1 DNA binding in obese patients. Obesity (Silver Spring) 17: 973-979, 2009.
26. Dela Peña A, Leclercq I, Field J, George J, Jones B and Farrell G: NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129: 1663-1674, 2005.
27. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J and Shoelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11: 183-190, 2005.
28. Singleton KD, Beckey VE and Wischmeyer PE: Glutamine prevents activation of NF-kappa B and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 24: 583-589, 2005.
29. Singleton KD and Wischmeyer PE: Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 292: R1839-R1845, 2007.
30. Huang Y, Li N, Liboni K and Neu J: Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine 22: 77-83, 2003.
31. Fan JG, Qian Y, Zheng XY, Cai XB and Lu YS: Effects of pentoxifyiline on hepatic nuclear factor-kappa B signaling pathway and insulin resistance in nonalcoholic steatohepatitis rats induced by fat-rich diet. Zhonghua Gan Zang Bing Za Zhi 14: 762-766, 2006 (In Chinese).